Trial Profile
A Phase III, Randomized, Double Blind, Non-inferiority, Comparative Study of the New Transdermal Patch Dosage Form Containing Loxoprofen Sodium (100 mg) and Loxonin (60 mg Tablet) for the Treatment of Acute Traumatic Injuries
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Jun 2020
Price :
$35
*
At a glance
- Drugs Loxoprofen (Primary) ; Loxoprofen
- Indications Pain
- Focus Registrational; Therapeutic Use
- Sponsors Daiichi Sankyo Brasil
- 13 Feb 2017 Status changed from recruiting to completed.
- 01 Dec 2015 New trial record